Bone regeneration sales will rise through 2035, driven by spinal disorders at 31.4% share of the application segment in 2025. Synthetic bone grafts account for 28.9% share of the product segment in 2025. The market is expected to reach USD 5,797.4 million in 2025 and USD 8,177.8 million by 2035.